Albemarle (ALB)
(Delayed Data from NYSE)
$100.84 USD
+0.91 (0.91%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $100.79 -0.05 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.84 USD
+0.91 (0.91%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $100.79 -0.05 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth F Momentum D VGM
Zacks News
Cal-Maine Foods to Acquire Assets of Featherland Egg Farms
by Zacks Equity Research
Cal-Maine Foods (CALM) inks deal to acquire the egg production, processing, sales and distribution business of Featherland Egg Farms.
5 Chemical Stocks That Are Poised for Solid Upside in Q4
by Anindya Barman
As the chemical industry's upturn is likely to continue in Q4, it would be prudent to zero in on these chemical stocks that have compelling prospects.
Why Should You Add Celanese (CE) to Your Portfolio Now?
by Anindya Barman
Strong fundamentals and compelling growth prospects make Celanese (CE) an attractive choice for investment.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Top Ranked Momentum Stocks to Buy for October 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 2nd:
Valvoline (VVV) Unit Opens VIOC Service Center in Uniondale
by Zacks Equity Research
Valvoline's (VVV) instant oil change service centers provide services like tire rotation, preventive maintenance services and replacement of safety parts.
5 Reasons to Add Albemarle (ALB) Stock to Your Portfolio Now
by Anindya Barman
Strong fundamentals and compelling growth prospects make Albemarle (ALB) an attractive choice for investment.
US Shale-Linked Chemical Spending Hits $200B: 5 Stocks to Buy
by Anindya Barman
The U.S. chemical industry is in the middle of a shale-induced investment boom leveraging access to abundant and cheap feedstocks.
Why Is Albemarle (ALB) Down 2.4% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Looks Good: Stock Adds 6.4% in Session
by Zacks Equity Research
Albemarle (ALB) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Albemarle (ALB) Tops Q2 Earnings Estimates, Raises FY18 View
by Anindya Barman
Albemarle (ALB) raised its adjusted earnings outlook for 2018 to $5.30-$5.50 per share.
Albemarle (ALB) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 6.25% and 6.80%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings to Watch on Aug 7: ALB, IFF, VSM
by Anindya Barman
Chemical companies are likely to gain from strategic actions and a favorable demand environment.
Can Lithium Help Albemarle (ALB) Beat Earnings Again in Q2?
by Anindya Barman
While Albemarle (ALB) faces certain headwinds in its Bromine and Catalysts businesses, it should gain from strength in its Lithium unit.
4 Chemical Stocks Poised to Outshine Q2 Earnings Estimates
by Zacks Equity Research
Chemical makers are seeing strong demand from the construction and automotive sectors.
Sinopec, Albemarle Ink Non-Binding Accord for Hydrocracking
by Zacks Equity Research
Sinopec's (SNP) subsidiaries and Albemarle will develop effective solutions for heavy feedstock hydrocracking for the global refining industry.
Albemarle (ALB) Down 6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Albemarle (ALB) Stock a Solid Choice Right Now?
by Zacks Equity Research
Albemarle (ALB) could be an interesting play for investors as it is seeing solid earnings estimate revision in addition to having a robust industry rank.
Here's Why You Should Add Albemarle (ALB) to Your Portfolio
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle (ALB) an attractive choice for investment.
Albemarle (ALB) Q1 Earnings Top Estimates on Lithium Strength
by Zacks Equity Research
Strong performance of the Lithium segment drove Albemarle's (ALB) Q1 results.
Will Lithium Unit Help Albemarle (ALB) Beat Earnings in Q1?
by Zacks Equity Research
Strong momentum in Albemarle's (ALB) core lithium business is likely to continue in Q1.
Albemarle Closes Sale of Part of Performance Catalysts Unit
by Zacks Equity Research
Albemarle (ALB) closes the sale of its polyolefin catalysts and components business to W. R. Grace & Co. for around $416 million.
Should Value Investors Pick Albemarle (ALB) Stock Now?
by Zacks Equity Research
Let's put Albemarle Corporation (ALB) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Albemarle (ALB) Down 16.3% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: DowDuPont, Albemarle and Monsanto
by Zacks Equity Research
Zacks Industry Outlook Highlights: DowDuPont, Albemarle and Monsanto